首页> 外文期刊>Cardiovascular Research >Regulation of β-adrenergic control of heart rate by GTP-cyclohydrolase 1 (GCH1) and tetrahydrobiopterin
【24h】

Regulation of β-adrenergic control of heart rate by GTP-cyclohydrolase 1 (GCH1) and tetrahydrobiopterin

机译:GTP-环水解酶1(GCH1)和四氢生物蝶呤调节β-肾上腺素能控制心率

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Clinical markers of cardiac autonomic function, such as heart rate and response to exercise, are important predictors of cardiovascular risk. Tetrahydrobiopterin (BH4) is a required cofactor for enzymes with roles in cardiac autonomic function, including tyrosine hydroxylase and nitric oxide synthase. Synthesis of BH4 is regulated by GTP cyclohydrolase I (GTPCH), encoded by GCH1. Recent clinical studies report associations between GCH1 variants and increased heart rate, but the mechanistic importance of GCH1 and BH4 in autonomic function remains unclear. We investigate the effect of BH4 deficiency on the autonomic regulation of heart rate in the hph-1 mouse model of BH4 deficiency.Methods and resultsIn the hph-1 mouse, reduced cardiac GCH1 expression, GTPCH enzymatic activity, and BH4 were associated with increased resting heart rate; blood pressure was not different. Exercise training decreased resting heart rate, but hph-1 mice retained a relative tachycardia. Vagal nerve stimulation in vitro induced bradycardia equally in hph-1 and wild-type mice both before and after exercise training. Direct atrial responses to carbamylcholine were equal. In contrast, propranolol treatment normalized the resting tachycardia in vivo. Stellate ganglion stimulation and isoproterenol but not forskolin application in vitro induced a greater tachycardic response in hph-1 mice. β1-adrenoceptor protein was increased as was the cAMP response to isoproterenol stimulation. Conclusion Reduced GCH1 expression and BH4 deficiency cause tachycardia through enhanced β-adrenergic sensitivity, with no effect on vagal function. GCH1 expression and BH4 are novel determinants of cardiac autonomic regulation that may have important roles in cardiovascular pathophysiology.
机译:目的心脏自主神经功能的临床标志物,例如心率和运动反应,是心血管风险的重要预测指标。四氢生物蝶呤(BH4)是在心脏自主功能中起作用的酶(包括酪氨酸羟化酶和一氧化氮合酶)必需的辅因子。 BH4的合成受GCH1编码的GTP环水解酶I(GTPCH)调控。最近的临床研究报道了GCH1变异体与心率增加之间的关联,但尚不清楚GCH1和BH4在植物神经功能中的机制重要性。方法和结果在hph-1小鼠中,心脏GCH1表达减少,GTPCH酶活性和BH4与静息增加相关,我们研究了BH4缺乏对BH4缺乏的hph-1小鼠心律自主调节的影响。心率;血压没有变化。运动训练降低了静息心率,但是hph-1小鼠保留了相对的心动过速。运动训练前后,体外迷走神经刺激均在hph-1和野生型小鼠中同样诱发心动过缓。心房对氨甲酰胆碱的直接反应相等。相反,普萘洛尔治疗可使体内静息性心动过速正常化。星状神经节刺激和异丙肾上腺素,但在体外未应用福司高林,在hph-1小鼠中引起更大的心动过速反应。 β1-肾上腺素受体蛋白增加,而对异丙肾上腺素刺激的cAMP反应也增加。结论GCH1表达降低和BH4缺乏可通过增强β-肾上腺素敏感性引起心动过速,而对迷走神经功能没有影响。 GCH1表达和BH4是心脏自主神经调节的新决定因素,可能在心血管病理生理中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号